Insider Sale: EVP and General Counsel Shirley Kuhlmann Sells 20,225 Shares of Collegium ...

GuruFocus.com09-07

On September 6, 2024, Shirley Kuhlmann, Executive Vice President and General Counsel of Collegium Pharmaceutical Inc (NASDAQ:COLL), sold 20,225 shares of the company. The transaction was documented in...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2465925604?lang=en_US&edition=fundamental","thumbnail":"https://s.yimg.com/uu/api/res/1.2/hEjRU3WlLKZz9eF40fFXJw--~B/aD01NDM7dz0xMjQyO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/us.finance.gurufocus/ed09ac10eff257f957ff589763732551","is_english":true,"pubTime":"2024-09-07 13:28","share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","id":"2465925604","market":"us","top_or_hot":-1,"title":"Insider Sale: EVP and General Counsel Shirley Kuhlmann Sells 20,225 Shares of Collegium ...","media":"GuruFocus.com","content":"<div>\n<p>On September 6, 2024, Shirley Kuhlmann, Executive Vice President and General Counsel of Collegium Pharmaceutical Inc (NASDAQ:COLL), sold 20,225 shares of the company. The transaction was documented in...</p>\n\n<a href=\"https://finance.yahoo.com/news/insider-sale-evp-general-counsel-052851473.html\">Source Link</a>\n\n</div>\n","source":"yahoofinance","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Insider Sale: EVP and General Counsel Shirley Kuhlmann Sells 20,225 Shares of Collegium ...</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nInsider Sale: EVP and General Counsel Shirley Kuhlmann Sells 20,225 Shares of Collegium ...\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-09-07 13:28 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/insider-sale-evp-general-counsel-052851473.html><strong>GuruFocus.com</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>On September 6, 2024, Shirley Kuhlmann, Executive Vice President and General Counsel of Collegium Pharmaceutical Inc (NASDAQ:COLL), sold 20,225 shares of the company. The transaction was documented in...</p>\n\n<a href=\"https://finance.yahoo.com/news/insider-sale-evp-general-counsel-052851473.html\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"EVP","symbol_name":"Eaton Vance Pennsylvania Municip","start_time":0,"source_url":"https://finance.yahoo.com/news/insider-sale-evp-general-counsel-052851473.html","article_id":"2465925604","we_media_id":null,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/hEjRU3WlLKZz9eF40fFXJw--~B/aD01NDM7dz0xMjQyO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/us.finance.gurufocus/ed09ac10eff257f957ff589763732551"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2465925604","pubTimestamp":1725686931,"sourceInfo":{"source_id":"yahoofinance","name":"雅虎金融"},"weMediaInfo":null,"summary":"On September 6, 2024, Shirley Kuhlmann, Executive Vice President and General Counsel of Collegium Pharmaceutical Inc , sold 20,225 shares of the company. The transaction was documented in a recent SEC Filing. Following this sale, the insider now owns 119,184 shares of the company.GuruFocus has detected 5 Warning Sign with COLL.Collegium Pharmaceutical Inc is focused on developing and commercializing treatments for pain management. The company aims to improve the quality of life for patients suffering from pain by providing innovative and effective pharmaceutical solutions.Over the past year, Shirley Kuhlmann has sold a total of 70,825 shares and has not made any purchases of the company's stock. This recent transaction is part of a broader trend seen within the company, where there have been 10 insider sells and no insider buys over the past year.","collect":0,"end_time":0,"defaultTopTitle":"yahoo.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"EVP":"Eaton Vance Pennsylvania Municip","BK4007":"制药","COLL":"Collegium Pharmaceutical, Inc."},"translate_title":"内幕出售：执行副总裁兼总法律顾问Shirley Kuhlmann出售20,225股Collegium股票...","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"EVP":1,"COLL":0.9},"content_text":"On September 6, 2024, Shirley Kuhlmann, Executive Vice President and General Counsel of Collegium Pharmaceutical Inc (NASDAQ:COLL), sold 20,225 shares of the company. The transaction was documented in a recent SEC Filing. Following this sale, the insider now owns 119,184 shares of the company.\n\nWarning! GuruFocus has detected 5 Warning Sign with COLL.\n\nCollegium Pharmaceutical Inc is focused on developing and commercializing treatments for pain management. The company aims to improve the quality of life for patients suffering from pain by providing innovative and effective pharmaceutical solutions.\nOver the past year, Shirley Kuhlmann has sold a total of 70,825 shares and has not made any purchases of the company's stock. This recent transaction is part of a broader trend seen within the company, where there have been 10 insider sells and no insider buys over the past year.\nShares of Collegium Pharmaceutical Inc were trading at $38.26 on the day of the sale. The company has a market cap of approximately $1.198 billion. The price-earnings ratio of the stock is 14.36, which is lower than both the industry median of 22.925 and the company's historical median.\nAccording to the GF Value, the intrinsic value of the stock is estimated at $30.10, making the current price-to-GF-Value ratio 1.27. This suggests that Collegium Pharmaceutical Inc is modestly overvalued.\n\nThe GF Value is calculated based on historical trading multiples such as the price-earnings ratio, price-sales ratio, price-book ratio, and price-to-free cash flow, along with a GuruFocus adjustment factor based on past returns and growth, and future business performance estimates from Morningstar analysts.\n\nThis sale by the insider might be of interest to current and potential investors, as it provides insight into the insider's perspective on the stock's valuation and future prospects.\nThis article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.This article first appeared on \nGuruFocus.","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2465925604"}